Skip to main content

Table 3 The prevention status characteristics of statin users and prescription in Jinshan Hospital, Shanghai

From: Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012–2018)

Cardiovascular prevention status

Value(%)

Primary prevention

32,147 (62.93)

Secondary prevention

18,936 (37.07)

Medical history

 Cerebrovascular disease

10,095 (21.68)

 Coronary artery disease

5461 (10.69)

 Peripheral artery disease

2622 (5.13)

 Percutaneous coronary intervention

471 (0.92)

 Hypertension

14,796 (28.96)

 Diabetes

5709 (11.18)

 Hyperlipidemia

12,394 (24.26)

 Renal disease

2042 (4.00)